Astrazeneca shot shows no increased clot risk after two doses

Blot clots are not more likely after second Astrazeneca jab, data published in The Lancet suggests.

Photo: Athit Perawongmetha/REUTERS / X02943

Astrazeneca's covid-19 vaccine doesn't raise the risk of a rare blood clotting disorder after a second dose, suggesting people shouldn't hesitate to get another one if they didn't have trouble after the first.

The estimated rate of the disorder, called thrombosis with thrombocytopenia syndrome (TTS), was 2.3 per million in people who received a second shot, according to data published in the medical journal The Lancet. That's comparable to what's found in an unvaccinated population. But the rate after a single dose was still higher, at 8.1 per million.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs